Abstract
A non-clonal mast cell activation syndrome is a newly emerged diagnosis. It shares the clinical features of anaphylaxis and mastocytosis despite having distinct mast cell biology. In this,paper we describe a series of patients representing the spectrum of non-clonal mast cell activation syndrome (nc-MCAS). We highlight the clinical manifestations of nc-MCAS as well as the diagnostic criteria and treatment options.
Original language | English |
---|---|
Pages (from-to) | 507-9, 540 |
Journal | Harefuah |
Volume | 154 |
Issue number | 8 |
State | Published - 1 Aug 2015 |